Item 7.01. Regulation FD Disclosure.
On
The furnishing of the attached press release is not an admission as to the
materiality of any information therein. The information contained in the press
release is summary information that is intended to be considered in the context
of more complete information included in the Company's filings with the
The information in Item 7.01 of this Current Report on Form 8-K and Exhibit 99.1 attached hereto is intended to be furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or the Exchange Act, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such filing.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits. Exhibit No. Description 99.1 Press Release issued byDeciphera Pharmaceuticals, Inc. onJanuary 11, 2021 , furnished herewith 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
--------------------------------------------------------------------------------
© Edgar Online, source